| Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer R Navab, D Strumpf, B Bandarchi, CQ Zhu, M Pintilie, VR Ramnarine, ... Proceedings of the National Academy of Sciences 108 (17), 7160-7165, 2011 | 432 | 2011 |
| Spatially confined sub-tumor microenvironments in pancreatic cancer BT Grünwald, A Devisme, G Andrieux, F Vyas, K Aliar, CW McCloskey, ... Cell 184 (22), 5577-5592. e18, 2021 | 414 | 2021 |
| Organoid cultures as preclinical models of non–small cell lung cancer R Shi, N Radulovich, C Ng, N Liu, H Notsuda, M Cabanero, ... Clinical Cancer Research 26 (5), 1162-1174, 2020 | 330 | 2020 |
| Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer R Navab, D Strumpf, C To, E Pasko, KS Kim, CJ Park, J Hai, J Liu, ... Oncogene 35 (15), 1899-1908, 2016 | 226 | 2016 |
| Epithelial-cadherin and β-catenin expression changes in pancreatic intraepithelial neoplasia MM Al-Aynati, N Radulovich, RH Riddell, MS Tsao Clinical Cancer Research 10 (4), 1235-1240, 2004 | 160 | 2004 |
| Recapitulating pancreatic tumor microenvironment through synergistic use of patient organoids and organ‐on‐a‐chip vasculature BFL Lai, RXZ Lu, Y Hu, L Davenport Huyer, W Dou, EY Wang, ... Advanced functional materials 30 (48), 2000545, 2020 | 146 | 2020 |
| Novel candidate tumor marker genes for lung adenocarcinoma K Wang, N Liu, N Radulovich, DA Wigle, MR Johnston, FA Shepherd, ... Oncogene 21 (49), 7598-7604, 2002 | 144 | 2002 |
| The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1 J Cullis, D Meiri, MJ Sandi, N Radulovich, OA Kent, M Medrano, ... Cancer cell 25 (2), 181-195, 2014 | 113 | 2014 |
| Tyrosyl phosphorylation of KRAS stalls GTPase cycle via alteration of switch I and II conformation Y Kano, T Gebregiworgis, CB Marshall, N Radulovich, BPK Poon, ... Nature communications 10 (1), 224, 2019 | 111 | 2019 |
| Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer IM Seiden-Long, KR Brown, W Shih, DA Wigle, N Radulovich, I Jurisica, ... Oncogene 25 (1), 91-102, 2006 | 104 | 2006 |
| Gab1 but not Grb2 mediates tumor progression in Met overexpressing colorectal cancer cells I Seiden-Long, R Navab, W Shih, M Li, J Chow, CQ Zhu, N Radulovich, ... Carcinogenesis 29 (3), 647-655, 2008 | 85 | 2008 |
| Lipocalin2 promotes invasion, tumorigenicity and gemcitabine resistance in pancreatic ductal adenocarcinoma L Leung, N Radulovich, CQ Zhu, S Organ, B Bandarchi, M Pintilie, C To, ... Public Library of Science 7 (10), e46677, 2012 | 84 | 2012 |
| Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis MM Al-Aynati, N Radulovich, J Ho, MS Tsao Clinical cancer research 10 (19), 6598-6605, 2004 | 81 | 2004 |
| SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling KL Thu, N Radulovich, DD Becker-Santos, LA Pikor, A Pusic, ... Oncogene 33 (3), 279-288, 2014 | 75 | 2014 |
| Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection FH Blackhall, M Pintilie, DA Wigle, I Jurisica, N Liu, N Radulovich, ... Neoplasia 6 (6), 761-767, 2004 | 70 | 2004 |
| Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer DMA Gendoo, RE Denroche, A Zhang, N Radulovich, GH Jang, M Lemire, ... PLoS computational biology 15 (1), e1006596, 2019 | 68 | 2019 |
| Towards personalized induction therapy for esophageal adenocarcinoma: organoids derived from endoscopic biopsy recapitulate the pre-treatment tumor MF Derouet, J Allen, GW Wilson, C Ng, N Radulovich, S Kalimuthu, ... Scientific reports 10 (1), 14514, 2020 | 57 | 2020 |
| Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma N Radulovich, NA Pham, D Strumpf, L Leung, W Xie, I Jurisica, MS Tsao Molecular cancer 9 (1), 24, 2010 | 50 | 2010 |
| The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors T Gebregiworgis, Y Kano, J St-Germain, N Radulovich, ML Udaskin, ... Nature communications 12 (1), 6274, 2021 | 49 | 2021 |
| Human pancreatic duct epithelial cell model for KRAS transformation N Radulovich, J Qian, MS Tsao Methods in enzymology 439, 1-13, 2008 | 49 | 2008 |
Ming TsaoUniversity of Toronto, University Health Network, Princess Margaret Cancer CentreVerified email at uhn.ca
